英诺特: 2025年限制性股票激励计划（草案）

Core Points - The company, Beijing Innotech Biotechnology Co., Ltd., has proposed a restricted stock incentive plan aimed at enhancing corporate governance and retaining talent while aligning the interests of shareholders and the core team [10][11][12] - The plan involves granting a total of 2,112,740 restricted shares, representing approximately 1.5483% of the company's total share capital, with an initial grant of 1,698,240 shares [2][16] - The grant price for the restricted shares is set at 16.55 yuan per share, with adjustments possible based on corporate actions [3][22] Summary by Sections Incentive Plan Overview - The incentive plan is based on various legal frameworks and aims to motivate key personnel through restricted stock [1][10] - The plan will not affect the company's compliance with listing requirements regarding share distribution [5] Grant Details - The total number of restricted shares to be granted is 2,112,740, with 1,698,240 shares for the initial grant and 414,500 shares reserved for future grants [2][16] - The plan specifies that the shares will be registered with the China Securities Depository and Clearing Corporation [2] Eligibility and Conditions - A total of 63 individuals are eligible for the initial grant, including directors, senior management, and key technical personnel [3][10] - The plan excludes independent directors and supervisors from participation [4][13] Performance Metrics - The performance assessment for the incentive plan will be based on company-level metrics, including revenue growth and product registration achievements [26][31] - The first assessment period will focus solely on product registration certificates, while subsequent periods will include revenue targets [27][28] Implementation Process - The plan requires approval from the shareholders' meeting and must be executed by the board of directors [33][34] - The board will oversee the implementation and ensure compliance with relevant regulations [11][12]